Do not polish
According to my observations of the Fed for decades, my experience is that the market is usually sold at the beginning of the meeting. Uncertainty about what the Fed can do or even say has created at least some sales that came into the meeting. Not this morning, the certainty that Powell will provide the market for the cavalry comes is the accepted wisdom. There is even a stubborn 30% who predicts the Fed will cut this week. This is a monumental complacency that will only lead to disappointment. Just look at how high-beta names are being executed, Amazon (NASDAQ: AMZN) interrupts $ 1
I will not mention the issue, but I think the market participants are likely to be disappointed tomorrow. I believe Powell will stay in the course and will not succumb to the market demands for lower interest rates at an inappropriate time. Those who are the same with the way I see that trading and speculation will shorten their positions and generate a pillow to finance the purchase in the upcoming sale
Adobe, The Trade Desk, Tesla
I supported Adobe NASDAQ): ADBE) for more than 5 years. It has become quite a large stock of cloud cloud with revenue growth of 20-30% on an annual basis. It trades 10% below its highest values. My discipline says that if you hold ADBE as a speculation, you have to reduce your position to profit. If you are looking for crop positions, ADBE must be listed. Trade Desk (NASDAQ: TTD) and TSLA are specific names I have defined as long-term speculation with similarly good results, albeit in a relatively shorter term. I recommended TTD at $ 190, yesterday reached $ 250, and TSLA is probably my most successful conversation for a long time. I called to sell it at about $ 300, and I called to keep it at $ 180 – $ 190, and I kept on sticking to the name, calling for it to rise by 100 points over time. However, at this point with TSLA trading over $ 230, it seems swinish not to take at least a bit of the table. I think this is for both TTD and TSLA, although they have much greater potential. I ask you to go through your speculative holdings and consider taking some profit. It is easier to sell positions when names rise, to eliminate the stress from selling a position that is only 10% higher a few minutes ago and threatens to go even lower.
Loyal readers know that I pay attention to the inner purchase. This gives me insight into areas of the market I do not know well and gives me investment ideas. Here are some interesting internal purchases:
Rupert Murdoch spends $ 21 million in Fox's inherited property (NASDAQ: FOX). Can FOX be underestimated?
Two in-house individuals spend $ 6,000,000 in Guess (NYSE: GES). GES is a hereditary business for jeans, can they be restructuring or product change and entering growth? GES is still a recognizable valuable brand. I'm not saying to buy, but if you understand consumer products and retail, maybe it's worth seeing them.
Intracellular Therapies (NASDAQ: ITCI): The director has bought nearly $ 2 million in shares. I have not hidden that I know more about biotechnology, but this purchase caught my eye. I remember that ITCI was a hot speculative biotech stock a few years ago, firing up to 60 dollars and then flaming in precision fashion. I can not help wondering that something could happen to ITCI.
Right now my position that Powell will not give the stock market or Trump what they want seems quite lonely. Soon we'll see if I'm right.
Editor's Note: The summary tags for this article were selected by Alfa's search editors.
Disclosure: I / I have no positions in the listed shares, and no plans to start any positions in the next 72 hours. I wrote this article alone and she expressed my own views. I do not get compensation for him (except from Seeking Alpha). I have no business relationship with any company whose shares are mentioned in this article.